Research & Development

B-Cell Plasticity Identified as a Driver of Lymphoma
Research & Development B-Cell Plasticity Identified as a Driver of Lymphoma

The immune system's most sophisticated soldiers, B cells programmed for a single mission, are now understood to possess a startling ability to shed their identity and revert to a dangerously flexible state. Groundbreaking research has unveiled a surprising twist in cellular biology, demonstrating

Breast Cancer Drug Combo Overcomes AML Resistance
Research & Development Breast Cancer Drug Combo Overcomes AML Resistance

For patients diagnosed with acute myeloid leukemia, a notoriously aggressive blood cancer, the current standard of care initially offers a powerful ray of hope, but this victory is often fleeting as the treatment almost always fails when the cancer learns to outsmart it. This life-saving therapy

Faulty Cell Death Fuels Small Cell Lung Cancer's Aggression
Research & Development Faulty Cell Death Fuels Small Cell Lung Cancer's Aggression

For patients diagnosed with the notoriously aggressive small cell lung cancer, the initial success of treatment often conceals a brutal truth about the formidable battle that lies ahead. This particular form of lung cancer presents one of modern oncology's most persistent and heartbreaking

New Study Tackles Brain Damage From Life-Saving Drugs
Research & Development New Study Tackles Brain Damage From Life-Saving Drugs

A profound paradox exists within modern pharmacology where the treatments designed to combat deadly diseases can simultaneously inflict severe and lasting damage on the human brain. For countless individuals undergoing treatment for conditions like HIV and cancer, this is a harsh reality; up to

CPRIT Awards $3M to Advance South Texas Cancer Research
Research & Development CPRIT Awards $3M to Advance South Texas Cancer Research

A new multi-million-dollar investment is poised to reshape the landscape of cancer research by focusing intensely on the unique health challenges faced by the communities of South Texas. The Cancer Prevention Research Institute of Texas (CPRIT) has announced a significant financial commitment of

Hidden Kinase State Is a New Therapeutic Target
Research & Development Hidden Kinase State Is a New Therapeutic Target

Within the intricate machinery of our cells, protein kinases serve as the master regulators, orchestrating a vast network of signals that control everything from cell growth to immune responses. They achieve this control through phosphorylation, the process of attaching a phosphate group to a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later